Zaloguj się

Gotowe bibliografie tematyczne / Osteoclasts / Książki

Książki na temat „Osteoclasts”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Osteoclasts.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 6 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Osteoclasts”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

R, Rifkin Barry, i Gay Carol V, red. Biology and physiology of the osteoclast. Boca Raton: CRC Press, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Yu, Hesheng. P2 purinoceptor-linked Ca2+ signaling and pH changes in osteoclasts. [Toronto: University of Toronto, Faculty of Dentistry], 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Felix, Bronner, Farach-Carson Mary C. 1958- i Rubin Janet, red. Bone resorption. London: Springer, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Rodionova, N. V. Funkt͡s︡ionalʹnai͡a︡ morfologii͡a︡ kletok v osteogeneze. Kiev: Nauk. dumka, 1989.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

National Institute on Aging/National Institute of Dental Research Workshop on Human Models of Skeletal Aging (1994 Washington, D.C.). National Institute on Aging/National Institute of Dental Research Workshop on Human Models of Skeletal Aging: Washington, DC, March 1-2, 1994. Redaktorzy Robey Pamela Gehron 1952-, Sherman Sherry, National Institute of Dental Research (U.S.) i National Institute on Aging. New York, NY: Springer International, 1995.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Maria, Bijvoet Olav Leonardus, Lipton Allan i International Cancer Congress (15th : 1990 : Hamburg, Germany), red. Osteoclast inhibition in the management of malignancy-related bone disorders: An international symposium held during the 15th International Cancer Congress, Hamburg, Germany, August 1990. Seattle: Hogrefe & Huber, 1993.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

D, Rubens R., i European Conference on Clinical Oncology (5th : 1989 : London, England), red. The Management of bone metastases and hypercalcaemia by osteoclast inhibition: An international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989. Toronto: Hogrefe & Huber, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Shorey, Seema. Differences in the degree to which osteoclasts from different parts of the skeleton employ cathepsin K and matrix metalloproteinases for bone resorption. Ottawa: National Library of Canada, 2002.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Holt, Ian. Control of osteoclast activity. Manchester: University of Manchester, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

David, Evered, Harnett Sara i Ciba Foundation, red. Cell and molecular biology of vertebrate hard tissues. Chichester, UK: Wiley, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

H, Helfrich Miep, i Ralston Stuart, red. Bone research protocols. Totowa, N.J: Humana Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

H, Helfrich Miep, i Ralston Stuart, red. Bone research protocols. Totowa, N.J: Humana Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Tai, Victoria. The effects of leukotriene Bb4s on osteoclast formation and osteoclastic bone resorption and the role of osteoblastic cells in these processes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Lorenzo, Joseph. Osteoimmunology: Interactions of the immune and skeletal systems. Amsterdam: Academic, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

R, Arnett Timothy, i Henderson Brian, red. Methods in bone biology. London: Chapman & Hall, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Green, Philip Macey. An experimental study of the osteoclast and its role in bone remodelling. Birmingham: University of Birmingham, 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Sutton, Michael Mark. The Influence of Microtubules and Microtubule-Based Structures on Osteoclast and CD4+ T Cell Function. [New York, N.Y.?]: [publisher not identified], 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Graziano, Victor M. A. The ferret: A potential in vitro small animal model for the study of osteogenesis and osteoclasis. [Toronto: University of Toronto, Faculty of Dentistry], 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Poore, Charles T. Osteotomy and Osteoclasis for Deformities of the Lower Extremities. Creative Media Partners, LLC, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Gabet, Yankel, Drorit Neumann, Ari Elson, Noam Levaot i Natalie A. Sims. Developmental Biology and Regulation of Osteoclasts. Frontier Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-867-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Brown, Alexander J. Osteoclasts: Morphology, Functions and Clinical Implications. Nova Science Publishers, Incorporated, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Reeves, Cecelia. Osteoclasts: Cell Biology, Functions and Related Diseases. Nova Science Publishers, Incorporated, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Yu, Hesheng. P2 purinoceptor-linked Ca2+ signaling and pH changes in osteoclasts. 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Bronner, Felix, Janet Rubin i Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Bronner, Felix, Janet Rubin i Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Anderson, Gail I. Osteoblast involvement in the formation and activation of osteoclasts in vitro. 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Chandra, Divya. To evaluate differences in mRNA expression of c-fms, EP2 and EP4 between large and small osteoclasts. 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Osteoblasts: Morphology, Functions and Clinical Implications. Nova Science Pub Inc, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Ruabens, Robert D. The Management of Bone Metastases and Hypercalcaemia by Osteoclast Inhibition: An International Symposium Held During the 5th European Conference on. Hogrefe & Huber Pub, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Zaidi, Mone. Osteoclast-Osteoblast. Jai Pr, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Clarke, Noel W. Metastatic disease in prostate cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0068.

Pełny tekst źródła

Streszczenie:

Metastases are the predominant cause of morbidity and death from prostate cancer (CaP). The tendency for cells to migrate from the primary site, enter the vascular/lymphatic circulation, and implant/grow at secondary sites is the principal discriminator of aggressive form indolent disease. But this process is poorly understood. Cells enter the circulation in increasing number as the disease progresses, impinging on endothelial surfaces, particularly in red bone marrow where they bind and transmigrate, forming early cell colonies. This requires chemo-attractants and nutrients enabling cellular survival. Established metastases thrive independently, disrupting local tissue, as characterized by progressive replacement of red bone marrow and disruption of skeletal architecture. Bone disruption includes massive overstimulation of both osteoblasts and osteoclasts, inducing synchronous over-production of abnormal bone and gross osteolysis.

Style APA, Harvard, Vancouver, ISO itp.

32

Lories, Rik J., i Georg Schett. Pathology: bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198734444.003.0010.

Pełny tekst źródła

Streszczenie:

Axial spondyloarthritis is associated with different types of skeletal damage. Inflammation at the affected sites is linked with both loss of trabecular bone and new bone formation on the cortical side, potentially leading to joint or spine ankylosis. Both aspects of the disease can result in a significant burden for the patient. Bone loss is directly linked to proinflammatory cytokines and activation of osteoclasts. Control of inflammation is therefore the best strategy to prevent loss of bone. The nature of the new bone formation process is less defined. A prominent role for developmental signalling pathways has been proposed. Current therapies have limited or no impact on this process. However, emerging data suggest that early control of disease activity may be part of a window of opportunity to prevent structural damage, as biomechanical factors and instability following inflammation may also play a role.

Style APA, Harvard, Vancouver, ISO itp.

33

Hall, Brian K. Bone, Volume II: The Osteoclast. CRC, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Hall, Brian K. Bone, Volume II: The Osteoclast. Taylor & Francis Group, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Bone Research Protocols (Methods in Molecular Medicine). Humana Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Helfrich, Miep H., i Stuart H. Ralston. Bone Research Protocols. Humana Press, 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Helfrich, Miep H., i Stuart H. Ralston. Bone Research Protocols. Humana Press, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Choi, Yongwon, Mark Horowitz, Joseph Lorenzo, Hiroshi Takayanagi i Georg Schett. Osteoimmunology: Interactions of the Immune and Skeletal Systems. Elsevier Science & Technology Books, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Choi, Yongwon, Mark Horowitz, Joseph Lorenzo, Hiroshi Takayanagi i Georg Schett. Osteoimmunology: Interactions of the Immune and Skeletal Systems. Elsevier Science & Technology Books, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Choi, Yongwon, Mark Horowitz, Joseph Lorenzo i Hiroshi Takayanagi. Osteoimmunology: Interactions of the Immune and Skeletal Systems. Elsevier Science & Technology Books, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Folkins, Alia. Coloring Book - You Will Get Better - Osteoclast. Independently Published, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Folkins, Alia. Coloring Book - You Will Get Better - Osteoclast. Independently Published, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Poore, Charles T. Osteotomy and Osteoclasis for Deformities of the Lower Extremities. Franklin Classics Trade Press, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Henderson, Brian, i T. Arnett. Methods in Bone Biology. Springer, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Osteoimmunology Interactions Of The Immune And Skeletal Systems Ii. Springer, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Lees, Rita L. Osteoclast heterogeneity: The importance of cell size and phase of activity. 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Sprague, Stuart M., i James M. Pullman. Spectrum of bone pathologies in chronic kidney disease. Redaktor David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0122.

Pełny tekst źródła

Streszczenie:

Histologic bone abnormalities begin very early in the course of chronic kidney disease. The KDIGO guidelines recommend that bone disease in patients with chronic kidney disease should be diagnosed on the basis of bone biopsy examination, with bone histomorphometry. They have also proposed a new classification system (TMV), using three key features of bone histology—turnover, mineralization, and volume—to describe bone disease in these patients. However, bone biopsy is still rarely performed today, as it involves an invasive procedure and highly specialized laboratory techniques. High-turnover bone disease (osteitis fibrosa cystica) is mainly related to secondary hyperparathyroidism and is characterized by increased rates of both bone formation and resorption, with extensive osteoclast and osteoblast activity, and a progressive increase in peritrabecular marrow space fibrosis. On the other hand, low-turnover (adynamic) bone disease involves a decline in osteoblast and osteoclast activities, reduced new bone formation and mineralization, and endosteal fibrosis. The pathophysiological mechanisms of adynamic bone include vitamin D deficiency, hyperphosphataemia, metabolic acidosis, inflammation, low oestrogen and testosterone levels, bone resistance to parathyroid hormone, and high serum fibroblast growth factor 23. Mixed uraemic osteodystrophy describes a combination of osteitis fibrosa and mineralization defect. In the past few decades, an increase in the prevalence of mixed uraemic osteodystrophy and adynamic bone disease has been observed.

Style APA, Harvard, Vancouver, ISO itp.

48

Sheraly, Aly R. The use of gastric proton pump inhibitors to modulate osteoclast-mediated resorption of calcium phosphate cements. 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

J. Singh, Parminder, i Rohit Kotnis. The musculoskeletal system: structure and function. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199550647.003.0003.

Pełny tekst źródła

Streszczenie:

♦ Structure of bone is comprised of cells, matrix, and water♦ Bone consists broadly of three surfaces (periosteal, endosteal, and Haversian) and two membranes (periosteum and endosteum)♦ The blood supply of bone is derived from four main routes (nutrient, metaphyseal, epiphyseal, and periosteal arteries)♦ There are three main types of cells in bone (osteoblast, osteocyte, and osteoclast)♦ The matrix is a composite material consisting of an organic and an inorganic component♦ Two types of bone formation are intramembranous and endochondral ossification♦ The skeleton is also involved in the vital homeostasis of calcium and phosphate.

Style APA, Harvard, Vancouver, ISO itp.

50

Bijvoet, O. L. M. Osteoclast Inhibition in the Management of Malignancy-Related Bone Disorders: An International Symposium Held During the 15th International Cancer Co. Hogrefe & Huber Pub, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!